Physical, chemical, and synthetic virology: Reprogramming viruses as controllable nanodevices.

The fields of physical, chemical, and synthetic virology work in partnership to reprogram viruses as controllable nanodevices. Physical virology provides the fundamental biophysical understanding of how virus capsids assemble, disassemble, display metastability, and assume various configurations. Chemical virology considers the virus capsid as a chemically addressable structure, providing chemical pathways to modify the capsid exterior, interior, and subunit interfaces. Synthetic virology takes an engineering approach, modifying the virus capsid through rational, combinatorial, and bioinformatics-driven design strategies. Advances in these three subfields of virology aim to develop virus-based materials and tools that can be applied to solve critical problems in biomedicine and biotechnology, including applications in gene therapy and drug delivery, diagnostics, and immunotherapy. Examples discussed include mammalian viruses, such as adeno-associated virus (AAV), plant viruses, such as cowpea mosaic virus (CPMV), and bacterial viruses, such as Qβ bacteriophage. Importantly, research efforts in physical, chemical, and synthetic virology have further unraveled the design principles foundational to the form and function of viruses. This article is categorized under: Diagnostic Tools > Diagnostic Nanodevices Biology-Inspired Nanomaterials > Protein and Virus-Based Structures.

[1]  B. Böttcher,et al.  A Conformational Change in the Adeno-Associated Virus Type 2 Capsid Leads to the Exposure of Hidden VP1 N Termini , 2005, Journal of Virology.

[2]  Jianzhong Wu,et al.  A molecular thermodynamic model for the stability of hepatitis B capsids. , 2014, The Journal of chemical physics.

[3]  K. Airenne,et al.  Targeting and purification of metabolically biotinylated baculovirus. , 2008, Human gene therapy.

[4]  N. Steinmetz,et al.  Photodynamic activity of viral nanoparticles conjugated with C60. , 2012, Chemical communications.

[5]  W. Stemmer,et al.  Molecular breeding of viruses , 2000, Nature Genetics.

[6]  Varpu Marjomäki,et al.  Enhanced gene delivery by avidin-displaying baculovirus. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Fabian J. Eber,et al.  RNA-controlled assembly of tobacco mosaic virus-derived complex structures: from nanoboomerangs to tetrapods. , 2015, Nanoscale.

[8]  F. Cosset,et al.  Targeted retroviral vectors displaying a cleavage site-engineered hemagglutinin (HA) through HA-protease interactions. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[9]  Partha Sarathi Banerjee,et al.  Chemoselective attachment of small molecule effector functionality to human adenoviruses facilitates gene delivery to cancer cells. , 2010, Journal of the American Chemical Society.

[10]  J. Kleinschmidt,et al.  Adeno-Associated Virus Type 2 Capsids with Externalized VP1/VP2 Trafficking Domains Are Generated prior to Passage through the Cytoplasm and Are Maintained until Uncoating Occurs in the Nucleus , 2006, Journal of Virology.

[11]  A. Zlotnick,et al.  Scaffold properties are a key determinant of the size and shape of self-assembled virus-derived particles. , 2013, ACS chemical biology.

[12]  F. Cosset,et al.  Selective transduction of protease-rich tumors by matrix-metalloproteinase-targeted retroviral vectors , 1999, Gene Therapy.

[13]  Trevor Douglas,et al.  Host–guest encapsulation of materials by assembled virus protein cages , 1998, Nature.

[14]  Theresa A. Storm,et al.  In Vitro and In Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses , 2008, Journal of Virology.

[15]  Junghae Suh,et al.  SCHEMA computational design of virus capsid chimeras: calibrating how genome packaging, protection, and transduction correlate with calculated structural disruption. , 2013, ACS synthetic biology.

[16]  A. Zlotnick,et al.  Hepatitis B virus core protein allosteric modulators can distort and disrupt intact capsids , 2018, eLife.

[17]  E. Ayuso,et al.  AAV-ID: A Rapid and Robust Assay for Batch-to-Batch Consistency Evaluation of AAV Preparations. , 2017, Molecular therapy : the journal of the American Society of Gene Therapy.

[18]  John E. Johnson,et al.  Quasi-equivalent viruses: a paradigm for protein assemblies. , 1997, Journal of molecular biology.

[19]  M. S. Chapman,et al.  Adeno-associated Virus (AAV) Assembly-Activating Protein Is Not an Essential Requirement for Capsid Assembly of AAV Serotypes 4, 5, and 11 , 2016, Journal of Virology.

[20]  Jason D. Perlmutter,et al.  Mechanisms of virus assembly. , 2014, Annual review of physical chemistry.

[21]  M. Young,et al.  Selective attachment and release of a chemotherapeutic agent from the interior of a protein cage architecture. , 2005, Chemical communications.

[22]  M. Kirpichnikov,et al.  Thermal conversion of filamentous potato virus X into spherical particles with different properties from virions , 2016, FEBS letters.

[23]  Lin Zhang,et al.  Biomolecular engineering of virus-like particles aided by computational chemistry methods. , 2015, Chemical Society reviews.

[24]  P. van der Schoot,et al.  Kinetics versus Thermodynamics in Virus Capsid Polymorphism. , 2016, The journal of physical chemistry. B.

[25]  F. Crick,et al.  Structure of Small Viruses , 1956, Nature.

[26]  S. Franzen,et al.  The Red clover necrotic mosaic virus capsid as a multifunctional cell targeting plant viral nanoparticle. , 2011, Bioconjugate chemistry.

[27]  A. Zlotnick,et al.  Mechanism of capsid assembly for an icosahedral plant virus. , 2000, Virology.

[28]  Jan C M van Hest,et al.  Stabilization of a Virus-Like Particle and Its Application as a Nanoreactor at Physiological Conditions , 2017, Biomacromolecules.

[29]  Andrew B. Martin,et al.  Generation of a bacterium with a 21 amino acid genetic code. , 2003, Journal of the American Chemical Society.

[30]  Qiangbin Wang,et al.  Encapsulation of Inorganic Nanomaterials inside Virus-Based Nanoparticles for Bioimaging , 2017, Nanotheranostics.

[31]  Jiansheng Liang,et al.  Cucumber mosaic virus as drug delivery vehicle for doxorubicin. , 2013, Biomaterials.

[32]  K. O'Neil,et al.  Phage display: protein engineering by directed evolution. , 1995, Current opinion in structural biology.

[33]  Gerd Folkers,et al.  Directed evolution of thymidine kinase for AZT phosphorylation using DNA family shuffling , 1999, Nature Biotechnology.

[34]  J. Bartlett,et al.  Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[35]  J. Kleinschmidt,et al.  Mutational Analysis of Narrow Pores at the Fivefold Symmetry Axes of Adeno-Associated Virus Type 2 Capsids Reveals a Dual Role in Genome Packaging and Activation of Phospholipase A2 Activity , 2005, Journal of Virology.

[36]  Nicole F Steinmetz,et al.  Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer. , 2017, ACS nano.

[37]  M. Finn,et al.  Stabilization of virus-like particles with poly(2-oxazoline)s. , 2011, Angewandte Chemie.

[38]  N. Steinmetz Viral nanoparticles as platforms for next-generation therapeutics and imaging devices. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[39]  A. Klug,et al.  Physical principles in the construction of regular viruses. , 1962, Cold Spring Harbor symposia on quantitative biology.

[40]  Steve Thorne,et al.  Directed Evolution Generates a Novel Oncolytic Virus for the Treatment of Colon Cancer , 2008, PloS one.

[41]  M. Barry,et al.  Avidin-based targeting and purification of a protein IX-modified, metabolically biotinylated adenoviral vector. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  John E. Johnson,et al.  Transferrin-mediated targeting of bacteriophage HK97 nanoparticles into tumor cells. , 2011, Nanomedicine.

[43]  K. Ulbrich,et al.  Coating of adeno‐associated virus with reactive polymers can ablate virus tropism, enable retargeting and provide resistance to neutralising antisera , 2008, The journal of gene medicine.

[44]  T. Gedeon,et al.  Encapsulation of an enzyme cascade within the bacteriophage P22 virus-like particle. , 2014, ACS chemical biology.

[45]  I. Holmes,et al.  AAV ANCESTRAL RECONSTRUCTION LIBRARY ENABLES SELECTION OF BROADLY INFECTIOUS VIRAL VARIANTS , 2015, Gene Therapy.

[46]  Nicole F. Steinmetz,et al.  Nanomanufacturing of Tobacco Mosaic Virus-Based Spherical Biomaterials Using a Continuous Flow Method , 2014, ACS biomaterials science & engineering.

[47]  David F. Savage,et al.  An open-hardware platform for optogenetics and photobiology , 2016, Scientific Reports.

[48]  Horst Kessler,et al.  Guiding plant virus particles to integrin-displaying cells. , 2012, Nanoscale.

[49]  H. Büning,et al.  Characterization of AAV vector particle stability at the single-capsid level , 2018, Journal of biological physics.

[50]  Inge J. Minten,et al.  Controlled encapsulation of multiple proteins in virus capsids. , 2009, Journal of the American Chemical Society.

[51]  Sonny C. Hsiao,et al.  Viral capsid DNA aptamer conjugates as multivalent cell-targeting vehicles. , 2009, Journal of the American Chemical Society.

[52]  P. Prevelige,et al.  Nanoreactors by programmed enzyme encapsulation inside the capsid of the bacteriophage P22. , 2012, ACS nano.

[53]  Stefan Lutz,et al.  Beyond directed evolution--semi-rational protein engineering and design. , 2010, Current opinion in biotechnology.

[54]  S. Harvey,et al.  Biophysical and Ultrastructural Characterization of Adeno-Associated Virus Capsid Uncoating and Genome Release , 2012, Journal of Virology.

[55]  R. Samulski,et al.  Mutagenesis of Adeno-Associated Virus Type 2 Capsid Protein VP1 Uncovers New Roles for Basic Amino Acids in Trafficking and Cell-Specific Transduction , 2010, Journal of Virology.

[56]  Ru Xiao,et al.  In Silico Reconstruction of the Viral Evolutionary Lineage Yields a Potent Gene Therapy Vector. , 2015, Cell reports.

[57]  D. Schaffer,et al.  Directed evolution of novel adeno-associated viruses for therapeutic gene delivery , 2012, Gene Therapy.

[58]  P. Prevelige,et al.  Use of the interior cavity of the P22 capsid for site-specific initiation of atom-transfer radical polymerization with high-density cargo loading. , 2012, Nature chemistry.

[59]  D. Curiel,et al.  Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus , 2007, Gene Therapy.

[60]  Eric J. Gomez,et al.  Tunable Protease-Activatable Virus Nanonodes , 2014, ACS nano.

[61]  J. Suh,et al.  Synthetic virology: engineering viruses for gene delivery. , 2014, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[62]  K. Ulbrich,et al.  Retargeting polymer‐coated adenovirus to the FGF receptor allows productive infection and mediates efficacy in a peritoneal model of human ovarian cancer , 2008, The journal of gene medicine.

[63]  K. Breitenkamp,et al.  Functional virus-based polymer-protein nanoparticles by atom transfer radical polymerization. , 2011, Journal of the American Chemical Society.

[64]  W. Stemmer,et al.  DNA shuffling of a family of genes from diverse species accelerates directed evolution , 1998, Nature.

[65]  Adam Zlotnick,et al.  Observed Hysteresis of Virus Capsid Disassembly Is Implicit in Kinetic Models of Assembly* , 2003, The Journal of Biological Chemistry.

[66]  Trevor Douglas,et al.  Viruses: Making Friends with Old Foes , 2006, Science.

[67]  M. Agbandje-McKenna,et al.  Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion , 2017, Proceedings of the National Academy of Sciences.

[68]  J. Suh,et al.  Reprogramming the Activatable Peptide Display Function of Adeno-Associated Virus Nanoparticles. , 2018, ACS nano.

[69]  Kai Jiang,et al.  Shaping bio-inspired nanotechnologies to target thrombosis for dual optical-magnetic resonance imaging. , 2015, Journal of materials chemistry. B.

[70]  Alan E. Smith,et al.  PEGylation of adenovirus with retention of infectivity and protection from neutralizing antibody in vitro and in vivo. , 1999, Human gene therapy.

[71]  R. Kumar,et al.  Targeted delivery system for cancer cells consist of multiple ligands conjugated genetically modified CCMV capsid on doxorubicin GNPs complex , 2016, Scientific Reports.

[72]  M. Finn,et al.  Tyrosine cross-linking reveals interfacial dynamics in adeno-associated viral capsids during infection. , 2012, ACS chemical biology.

[73]  N. Steinmetz,et al.  Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[74]  H. Naitow,et al.  Crystal structure of tobacco necrosis virus at 2.25 A resolution. , 2000, Journal of molecular biology.

[75]  Nicole F Steinmetz,et al.  Intravital imaging of human prostate cancer using viral nanoparticles targeted to gastrin-releasing Peptide receptors. , 2011, Small.

[76]  Jason E Hein,et al.  Copper-catalyzed azide-alkyne cycloaddition (CuAAC) and beyond: new reactivity of copper(I) acetylides. , 2010, Chemical Society reviews.

[77]  Sanjay Kumar,et al.  Conjugate-Based Targeting of Recombinant Adeno-Associated Virus Type 2 Vectors by Using Avidin-Linked Ligands , 2002, Journal of Virology.

[78]  M. Finn,et al.  Crosslinking of and coupling to viral capsid proteins by tyrosine oxidation. , 2004, Chemistry & biology.

[79]  R. Samulski,et al.  Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism , 2016, Gene Therapy.

[80]  Albert J R Heck,et al.  High-resolution mass spectrometry of viral assemblies: Molecular composition and stability of dimorphic hepatitis B virus capsids , 2008, Proceedings of the National Academy of Sciences.

[81]  N. Steinmetz,et al.  To Target or Not to Target: Active vs. Passive Tumor Homing of Filamentous Nanoparticles Based on Potato virus X , 2015, Cellular and Molecular Bioengineering.

[82]  P. Sengar,et al.  Multifunctionalized biocatalytic P22 nanoreactor for combinatory treatment of ER+ breast cancer , 2018, Journal of Nanobiotechnology.

[83]  S. Russell,et al.  Directed evolution of retroviruses activatable by tumour-associated matrix metalloproteases , 2003, Gene Therapy.

[84]  I. Kuhn,et al.  OvAd1, a Novel, Potent, and Selective Chimeric Oncolytic Virus Developed for Ovarian Cancer by 3D-Directed Evolution , 2016, Molecular therapy oncolytics.

[85]  Y. Oum,et al.  Altering adenoviral tropism via click modification with ErbB specific ligands. , 2012, Bioconjugate chemistry.

[86]  P. Vachette,et al.  Kinetic study of the self-assembly of brome mosaic virus capsid , 1987, European Biophysics Journal.

[87]  Adam Zlotnick,et al.  Theoretical aspects of virus capsid assembly , 2005, Journal of molecular recognition : JMR.

[88]  Jeffrey J. Tabor,et al.  Light-Activated Nuclear Translocation of Adeno-Associated Virus Nanoparticles Using Phytochrome B for Enhanced, Tunable, and Spatially Programmable Gene Delivery. , 2016, ACS nano.

[89]  David T. Curiel,et al.  Engineering targeted viral vectors for gene therapy , 2007, Nature Reviews Genetics.

[90]  D. Schaffer,et al.  Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

[91]  Mauricio G. Mateu,et al.  Virus engineering: functionalization and stabilization. , 2011, Protein engineering, design & selection : PEDS.

[92]  Jan C M van Hest,et al.  Sortase A-Mediated N-Terminal Modification of Cowpea Chlorotic Mottle Virus for Highly Efficient Cargo Loading. , 2015, Bioconjugate chemistry.

[93]  Sarah S. Staniland,et al.  Bioinspired nanoreactors for the biomineralisation of metallic-based nanoparticles for nanomedicine. , 2015, Physical chemistry chemical physics : PCCP.

[94]  B. Byrne,et al.  Structural Insight into the Unique Properties of Adeno-Associated Virus Serotype 9 , 2012, Journal of Virology.

[95]  K. Lam,et al.  Chemically activatable viral capsid functionalized for cancer targeting. , 2016, Nanomedicine.

[96]  M. Liberman,et al.  Cochlear gene therapy with ancestral AAV in adult mice: complete transduction of inner hair cells without cochlear dysfunction , 2017, Scientific Reports.

[97]  Claus V. Hallwirth,et al.  Germline viral “fossils” guide in silico reconstruction of a mid-Cenozoic era marsupial adeno-associated virus , 2016, Scientific Reports.

[98]  Partha Sarathi Banerjee,et al.  Unnatural Amino Acid Incorporation onto Adenoviral (Ad) Coat Proteins Facilitates Chemoselective Modification and Retargeting of Ad Type 5 Vectors , 2011, Journal of Virology.

[99]  A. Zlotnick,et al.  The thermodynamics of virus capsid assembly. , 2009, Methods in enzymology.

[100]  A. Zlotnick,et al.  To build a virus capsid. An equilibrium model of the self assembly of polyhedral protein complexes. , 1994, Journal of molecular biology.

[101]  M. Hagan,et al.  Recent advances in coarse-grained modeling of virus assembly. , 2016, Current opinion in virology.

[102]  N. Steinmetz,et al.  Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[103]  A. Ting,et al.  Site-specific modification of AAV vector particles with biophysical probes and targeting ligands using biotin ligase. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[104]  Sek-Man Wong,et al.  In vitro-reassembled plant virus-like particles for loading of polyacids. , 2006, The Journal of general virology.

[105]  Uri Raviv,et al.  RNA encapsidation by SV40-derived nanoparticles follows a rapid two-state mechanism. , 2012, Journal of the American Chemical Society.

[106]  Nico A J M Sommerdijk,et al.  A virus-based single-enzyme nanoreactor. , 2007, Nature nanotechnology.

[107]  S. Spence,et al.  Redirected infection of directly biotinylated recombinant adenovirus vectors through cell surface receptors and antigens. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[108]  T. Douglas,et al.  Atom transfer radical polymerization on the interior of the P22 capsid and incorporation of photocatalytic monomer crosslinks , 2013 .

[109]  M. Hagan Modeling Viral Capsid Assembly. , 2013, Advances in chemical physics.

[110]  Jennifer A. Prescher,et al.  A comparative study of bioorthogonal reactions with azides. , 2006, ACS chemical biology.

[111]  K. Breitenkamp,et al.  Encapsidated Atom-Transfer Radical Polymerization in Qβ Virus-like Nanoparticles , 2014, ACS nano.

[112]  J. Suh,et al.  Efficiency of Protease-Activatable Virus Nanonodes Tuned Through Incorporation of Wild-Type Capsid Subunits , 2014 .

[113]  J. Flannery,et al.  Molecular evolution of adeno-associated virus for enhanced glial gene delivery. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[114]  Manidipa Banerjee,et al.  In vitro assembly of polymorphic virus-like particles from the capsid protein of a nodavirus. , 2016, Virology.

[115]  Eric J. Gomez,et al.  Stimulus‐responsive viral vectors for controlled delivery of therapeutics , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[116]  M. Young,et al.  Targeting and photodynamic killing of a microbial pathogen using protein cage architectures functionalized with a photosensitizer. , 2007, Langmuir : the ACS journal of surfaces and colloids.

[117]  D. Caspar Structure of Bushy Stunt Virus , 1956, Nature.

[118]  Bogdan Dragnea,et al.  Self-assembly of brome mosaic virus capsids: insights from shorter time-scale experiments. , 2008, The journal of physical chemistry. A.

[119]  S. Ylä-Herttuala,et al.  Avidin-biotin technology in targeted therapy , 2010, Expert opinion on drug delivery.

[120]  Theresa A. Storm,et al.  Rapid Uncoating of Vector Genomes Is the Key toEfficient Liver Transduction with Pseudotyped Adeno-Associated VirusVectors , 2004, Journal of Virology.

[121]  N. Stephanopoulos,et al.  Dual-surface modified virus capsids for targeted delivery of photodynamic agents to cancer cells. , 2010, ACS nano.

[122]  Mauricio G Mateu,et al.  Mechanical disassembly of single virus particles reveals kinetic intermediates predicted by theory. , 2012, Biophysical journal.

[123]  Neil R. Voss,et al.  Engineered mutations change the structure and stability of a virus-like particle. , 2012, Biomacromolecules.

[124]  K. Ulbrich,et al.  Polymer-coated adenovirus permits efficient retargeting and evades neutralising antibodies , 2001, Gene Therapy.

[125]  B. Sumerlin,et al.  Poly(N-(2-hydroxypropyl) methacrylamide)-based nanotherapeutics , 2014 .

[126]  Jacob M Hooker,et al.  Interior surface modification of bacteriophage MS2. , 2004, Journal of the American Chemical Society.

[127]  J. Rudnick,et al.  Assembly of viruses and the pseudo-law of mass action. , 2009, The Journal of chemical physics.

[128]  Helena Berglund,et al.  Improved solubility of TEV protease by directed evolution. , 2006, Journal of biotechnology.

[129]  R. Nolte,et al.  Modular, Bioorthogonal Strategy for the Controlled Loading of Cargo into a Protein Nanocage , 2018, Bioconjugate chemistry.

[130]  Adam Zlotnick,et al.  Regulating self-assembly of spherical oligomers. , 2005, Nano letters.

[131]  Jiyong Lee,et al.  Dual Functionalized Bacteriophage Qβ as a Photocaged Drug Carrier. , 2016, Small.

[132]  A. Zlotnick,et al.  Weak protein-protein interactions are sufficient to drive assembly of hepatitis B virus capsids. , 2002, Biochemistry.

[133]  N. Dokholyan,et al.  Intra- and Inter-Subunit Disulfide Bond Formation Is Nonessential in Adeno-Associated Viral Capsids , 2012, PloS one.

[134]  S. Codd,et al.  High-density targeting of a viral multifunctional nanoplatform to a pathogenic, biofilm-forming bacterium. , 2007, Chemistry & biology.

[135]  P. Banerjee,et al.  Targeted and armed oncolytic adenovirus via chemoselective modification. , 2011, Bioorganic & medicinal chemistry letters.

[136]  R. Garcea,et al.  In vitro papillomavirus capsid assembly analyzed by light scattering. , 2004, Virology.

[137]  J. Seffernick,et al.  Novel enzyme activities and functional plasticity revealed by recombining highly homologous enzymes. , 2001, Chemistry & biology.

[138]  N. G. Lemcoff,et al.  Intramolecular Cross-Linking Methodologies for the Synthesis of Polymer Nanoparticles. , 2016, Chemical reviews.

[139]  S. Lommel,et al.  Loading and release mechanism of red clover necrotic mosaic virus derived plant viral nanoparticles for drug delivery of doxorubicin. , 2014, Small.

[140]  Daniel Luque,et al.  Assembling Enzymatic Cascade Pathways inside Virus-Based Nanocages Using Dual-Tasking Nucleic Acid Tags , 2017, Journal of the American Chemical Society.

[141]  S. Stahl,et al.  A theoretical model successfully identifies features of hepatitis B virus capsid assembly. , 1999, Biochemistry.

[142]  M. Francis,et al.  Dual-surface modification of the tobacco mosaic virus. , 2005, Journal of the American Chemical Society.

[143]  Florence Tama,et al.  The mechanism and pathway of pH induced swelling in cowpea chlorotic mottle virus. , 2002, Journal of molecular biology.

[144]  John E. Johnson,et al.  Pseudo-atomic models of swollen CCMV from cryo-electron microscopy data. , 2003, Journal of structural biology.

[145]  B. Böttcher,et al.  The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes , 2011, Journal of Virology.

[146]  P. Stewart,et al.  Detection and imaging of aggressive cancer cells using an epidermal growth factor receptor (EGFR)-targeted filamentous plant virus-based nanoparticle. , 2015, Bioconjugate chemistry.

[147]  M. Chillón,et al.  Adenovirus complexed with polyethylene glycol and cationic lipid is shielded from neutralizing antibodies in vitro , 1998, Gene Therapy.

[148]  Fabian J. Eber,et al.  The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft‐Matter Nanorods , 2015, Advanced healthcare materials.

[149]  Qiangbin Wang,et al.  Insights into stabilization of a viral protein cage in templating complex nanoarchitectures: roles of disulfide bonds. , 2014, Small.

[150]  J. Kaufman,et al.  Separation and crystallization of T = 3 and T = 4 icosahedral complexes of the hepatitis B virus core protein. , 1999, Acta crystallographica. Section D, Biological crystallography.

[151]  A C Evans,et al.  Biocomputing nanoplatforms as therapeutics and diagnostics. , 2016, Journal of controlled release : official journal of the Controlled Release Society.

[152]  W. Stemmer DNA shuffling by random fragmentation and reassembly: in vitro recombination for molecular evolution. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[153]  Andries Zijlstra,et al.  Viral nanoparticles as tools for intravital vascular imaging , 2006, Nature Medicine.

[154]  R. Samulski,et al.  Structure and Dynamics of Adeno-Associated Virus Serotype 1 VP1-Unique N-Terminal Domain and Its Role in Capsid Trafficking , 2013, Journal of Virology.

[155]  Vijay S Reddy,et al.  Invariant polymorphism in virus capsid assembly. , 2009, Journal of the American Chemical Society.

[156]  S. Franzen,et al.  Infusion of dye molecules into Red clover necrotic mosaic virus. , 2008, Chemical communications.

[157]  J. Suh,et al.  Role of Tetra Amino Acid Motif Properties on the Function of Protease-Activatable Viral Vectors. , 2016, ACS biomaterials science & engineering.

[158]  M. R. Delgado Alvira,et al.  Clades of Adeno-Associated Viruses Are Widely Disseminated in Human Tissues , 2004, Journal of Virology.

[159]  Marianne Manchester,et al.  Folic acid-mediated targeting of cowpea mosaic virus particles to tumor cells. , 2007, Chemistry & biology.

[160]  Rachel E Kelemen,et al.  A Precise Chemical Strategy To Alter the Receptor Specificity of the Adeno-Associated Virus. , 2016, Angewandte Chemie.

[161]  M. Croyle,et al.  PEGylated Adenoviruses: From Mice to Monkeys , 2010, Viruses.

[162]  Alan E. Rowan,et al.  Catalytic capsids: the art of confinement , 2011 .

[163]  Kai Jiang,et al.  Tobacco mosaic virus rods and spheres as supramolecular high-relaxivity MRI contrast agents. , 2013, Journal of materials chemistry. B.

[164]  Mikhail G. Shapiro,et al.  In Vivo Selection of a Computationally Designed SCHEMA AAV Library Yields a Novel Variant for Infection of Adult Neural Stem Cells in the SVZ. , 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

[165]  Peter G. Schultz,et al.  A chemical toolkit for proteins — an expanded genetic code , 2006, Nature Reviews Molecular Cell Biology.

[166]  Sek-Man Wong,et al.  Folic acid-conjugated protein cages of a plant virus: a novel delivery platform for doxorubicin. , 2007, Bioconjugate chemistry.

[167]  Peter Krolla-Sidenstein,et al.  Modified TMV Particles as Beneficial Scaffolds to Present Sensor Enzymes , 2015, Front. Plant Sci..

[168]  D. Schaffer,et al.  Directed evolution of adeno-associated virus to an infectious respiratory virus , 2009, Proceedings of the National Academy of Sciences.

[169]  M. Young,et al.  Protein Engineering of a Viral Cage for Constrained Nanomaterials Synthesis , 2002 .

[170]  D L Caspar,et al.  Movement and self-control in protein assemblies. Quasi-equivalence revisited. , 1980, Biophysical journal.

[171]  M. G. Mateu,et al.  Imaging and Quantitation of a Succession of Transient Intermediates Reveal the Reversible Self-Assembly Pathway of a Simple Icosahedral Virus Capsid. , 2016, Journal of the American Chemical Society.

[172]  R. McKenna,et al.  Thermal Stability as a Determinant of AAV Serotype Identity , 2017, Molecular therapy. Methods & clinical development.

[173]  H. Nakai,et al.  Drawing a high-resolution functional map of adeno-associated virus capsid by massively parallel sequencing , 2014, Nature Communications.

[174]  K. Cichutek,et al.  Liver cancer protease activity profiles support therapeutic options with matrix metalloproteinase-activatable oncolytic measles virus. , 2010, Cancer research.

[175]  Demin Zhou,et al.  Precision Fluorescent Labeling of an Adeno-Associated Virus Vector to Monitor the Viral Infection Pathway. , 2018, Biotechnology journal.

[176]  John E. Johnson,et al.  Functional implications of quasi-equivalence in a T = 3 icosahedral animal virus established by cryo-electron microscopy and X-ray crystallography. , 1994, Structure.